stella
beta
A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions — Stella
Recruiting
Back to For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(2 sites)
China
Peking University People's Hospital, Beijing, Beijing Municipality
Henan Provincial People's Hospital, Zhengzhou, Henan
View full record on ClinicalTrials.gov